![]()
26
| 1 | 2005
Klinisk Biokemi i Norden
16. Pollock MA, Sturrock A, Marshall K, Davidson
KM, Kelly CJG, McMahon AD, et al. Thyroxine
treatment in patients with symptoms of hypo-
thyroidism but thyroid function tests with-
in the reference range: randomised double-
blind placebo controlled cross over trial. BMJ
2001;323:891-5.
17. Kaplan MM, Sarne DH, Schneider AB. In search
of the impossible dream? Thyroid hormone
replacement therapy that treats all symptoms
in all hypothyroid patients. J Clin Endocrinol
Metab 2003;88:4540-2
18. McMillan CV, Bradley C, Woodcock A, Razvi
S, Weaver JU. Design of new questionnaires to
measure quality of life and treatment satisfac-
tion in hypothyroidism. Thyroid 2004;14:916-
25.
19. Saravanan P, Simmons DJ, Greenwood R, Peters
TJ, Dayan CM. Partial substitution of thyroxine
with tri-iodothyronine in patients on thyroxine
replacement therapy: results of a large commu-
nity-based randomised controlled trial. J Clin
Endocrinol Metab, accepterat 2004 doi:10.1210/
jc.2004-1672.
20. Díez JJ, Iglesias P. Spontaneous subclini-
cal hypothyroidism in patients older than
55 years: an analysis of natural course and
risk factors for the development of overt
thyroid failure. J Clin Endocrinol Metab
2004;89:4890-7.
21. Vanderpump MPJ, Tunbridge WMG, French JM,
Appleton D, Bates D, Rodgers H et al. The inci-
dence of thyroid disorders in the community; a
twenty year follow up of the Whickham survey.
Clin Endocrinol 1995;43:55-68.
22. Lindstedt G, Lundberg P, Sundbeck G, Edén
S, Eggertsen R, Nyström E. TSH och TPOAb
bör vara förstahandsanalyser vid misstänkt
tyreoideafunktionsrubbning. Läkartidningen
2000;97:3913-6.
23. Warren RE, Perros P, Nyirenda MJ, Frier BM.
Serum thyrotropin is a better predictor of future
thyroid dysfunction than thyroid autoantibody
status in biochemically euthyroid patients with
diabetes: implications for screening. Thyroid
2004;14:853-7.
24. Scofield RH. Autoantibodies as predictors of
disease. Lancet 2004:363:1544-6.
25. Eisenbarth GS, Gottlieb PA. Medical progress
– Autoimmune polyendocrine syndromes. N
Engl J Med 2004:350:2068-79.
26. Jankowski RF. Implementing national guidelines
at local level. Changes in clinicians’ behaviour in
primary care need to be reflected in secondary
care. BMJ 2001;322:1258-9. (se även Editor´s
choice. Change: both desired and resisted. BMJ
2001;322:0 http://bmj.bmjjournals.com/cgi/con-
tent/full/322/7297/0
27. Gharib H, Tuttle RM, Baskin HJ, Fish LH,
Singer PA, McDermott MT. Subclinical thy-
roid dysfunction: a joint statement on man-
agement from the American Association of
Clinical Endocrinologists, the American Thyroid
Association, and the Endocrine Society. J Clin
Endocrinol Metab. 2005;90:581-5 (se också
efterföljande kommentar och editorial, pp. 586-
90).
28. Ringel MD, Ernest L. Mazzaferri EL. Editorial.
Subclinical thyroid dysfunction—can there
be a consensus about the consensus? J Clin
Endocrinol Metab 2005;90:588-90.
29. Fantz CR, Dagogo-Jack S, Ladenson JH,
Gronowski AM. Thyroid function during preg-
nancy Clin Chem 1999; 45:2250 -8.
30. Panesar NS, Li CY, Rogers MS. Reference inter-
vals for thyroid hormones in pregnant Chinese
women. Ann Clin Biochem 2001;38:329-32.
31. Andersen S, Bruun NH, Pedersen KM, Laurberg
P. Biologic variation is important for inter-
pretation of thyroid function tests. Thyroid
2003;13:1069-78.
32. Lindstedt G, Lundberg PA, Björn-Rasmussen
E, Magnussen B. Serum-ferritin and iron-defi-
ciency anaemia in hospital patients. Lancet
1980;1:205-6.
33. Lundberg PA, Lindstedt G, Andersson T,
Branegård B, Lundquister G, Nyström E. Increase
in serum ferritin concentration induced by fast-
ing. Clin Chem 1984;30:161-3.
34. Hulthén L, Lindstedt G, Lundberg PA, Hallberg L.
Effectofamildinfectiononserumferritinconcen-
tration–clinicalandepidemiologicalimplications.
Eur J Clin Nutr 1998;52:376-9.
